Pelthos Therapeutics Inc.

Pelthos Therapeutics Inc.

Biotechnology • Healthcare • Durham, NC, United States • PTHS (ASE)

Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older. It also provides NITRICIL, a proprietary nitric oxide-based technology platform. The company was formerly known as Channel Therapeutics Corporation and changed its name to Pelthos Therapeutics Inc. in July 2025. Pelthos Therapeutics Inc. was founded in 2002 and is based in Durham, North Carolina.

877 265 8266 4020 Stirrup Creek Drive, Durham, NC 27703, United States

Stock Performance (90 Days)

Data through Dec 29, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Pelthos Therapeutics Acquires Global Rights to Xeglyze - TipRanks
TipRanks • Jan 2
Pelthos Therapeutics Expands Board of Directors with the Appointment of Andrew Einhorn - Yahoo Finance
Yahoo Finance • Dec 23
Pelthos Therapeutics Signs Multiple Material Agreements - TradingView — Track All Markets
TradingView — Track All Markets • Jan 2
Pelthos Therapeutics stock falls after acquisition of impetigo treatment - Investing.com
Investing.com • Nov 7
Pelthos Pharmaceuticals: Off To A Strong Start With Zelsuvmi, Continued Sales Growth Is Likely - Seeking Alpha
Seeking Alpha • Dec 1

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has Pelthos Therapeutics Inc. had layoffs?
No layoff events have been recorded for Pelthos Therapeutics Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does Pelthos Therapeutics Inc. have?
Pelthos Therapeutics Inc. has approximately 4 employees.
What industry is Pelthos Therapeutics Inc. in?
Pelthos Therapeutics Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is Pelthos Therapeutics Inc. a publicly traded company?
Yes, Pelthos Therapeutics Inc. is publicly traded under the ticker symbol PTHS on the ASE. The company has a market capitalization of approximately $0.08 billion.
Where is Pelthos Therapeutics Inc. headquartered?
Pelthos Therapeutics Inc. is headquartered in Durham, NC, United States at 4020 Stirrup Creek Drive, Durham, NC 27703, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.